USD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$8.04M
Market Cap
-
P/E Ratio
-3.31
EPS
$2.65
52 Week High
$0.72
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $3.8M |
Total Revenue | $120M |
Cost Of Revenue | $116M |
Costof Goods And Services Sold | $116M |
Operating Income | -$1M |
Selling General And Administrative | $3.3M |
Research And Development | - |
Operating Expenses | $4.9M |
Investment Income Net | - |
Net Interest Income | $93K |
Interest Income | $93K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $6M |
Income Before Tax | -$951K |
Income Tax Expense | $504K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1M |
Ebitda | $5M |
Net Income | $10M |
Field | Value (USD) |
---|---|
Total Assets | $64M |
Total Current Assets | $60M |
Cash And Cash Equivalents At Carrying Value | $13M |
Cash And Short Term Investments | $13M |
Inventory | $9.8M |
Current Net Receivables | $30M |
Total Non Current Assets | $4.8M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $3.3M |
Intangible Assets Excluding Goodwill | $3.3M |
Goodwill | $1.5M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $6.9M |
Other Non Current Assets | - |
Total Liabilities | $35M |
Total Current Liabilities | $34M |
Current Accounts Payable | $20M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $10M |
Total Non Current Liabilities | $492K |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | $10M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $10M |
Other Current Liabilities | $2.5M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $30M |
Treasury Stock | - |
Retained Earnings | -$63M |
Common Stock | $1.4M |
Common Stock Shares Outstanding | $5.5M |
Field | Value (USD) |
---|---|
Operating Cashflow | $1.2M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $6M |
Capital Expenditures | $615K |
Change In Receivables | - |
Change In Inventory | $406K |
Profit Loss | - |
Cashflow From Investment | -$18M |
Cashflow From Financing | $1.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $10M |
Field | Value (USD) |
---|---|
Gross Profit | $3.8M |
Total Revenue | $120M |
Cost Of Revenue | $116M |
Costof Goods And Services Sold | $116M |
Operating Income | -$1M |
Selling General And Administrative | $3.3M |
Research And Development | - |
Operating Expenses | $4.9M |
Investment Income Net | - |
Net Interest Income | $93K |
Interest Income | $93K |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $6M |
Income Before Tax | -$951K |
Income Tax Expense | $504K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.5M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1M |
Ebitda | $5M |
Net Income | $10M |
Sector: HEALTHCARE
Industry: PHARMACEUTICAL RETAILERS
Ridgetech, Inc. (RDGT) is a leading distributor in the pharmaceutical and healthcare sector, primarily operating within the People's Republic of China. Based in Hangzhou, the company capitalizes on its expansive network of drugstores to offer a wide array of quality healthcare products, thereby addressing the increasing demand for accessible medical solutions in the region. With a strong grasp of the local market and regulatory frameworks, Ridgetech has established itself as a reliable partner in the dynamic and rapidly evolving Chinese healthcare landscape, committed to enhancing consumer access to essential pharmaceutical resources.